Citation Impact
Citing Papers
Reconstituting Organ-Level Lung Functions on a Chip
2010 StandoutScience
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
2009 StandoutNature
THE CELLULAR AND MOLECULAR MECHANISMS OF DIABETIC COMPLICATIONS
1996
Apoptosis in the nervous system
2000 StandoutNature
Developmental Control of Blood Cell Migration by the Drosophila VEGF Pathway
2002
Inflammation and metabolic disorders
2006 StandoutNature
The role of increased liver triglyceride content: a culprit of diabetic hyperglycaemia?
2002
The Ubiquitin Proteasome System in Neurodegenerative Diseases
2003 StandoutNobel
Advanced glycation and endothelial functions: A link towards vascular complications in diabetes
2004
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
2000 StandoutNature
Scavenger Receptor Class B Type I-mediated Reverse Cholesterol Transport Is Inhibited by Advanced Glycation End Products
2001
Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
1996 Standout
The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration
2003
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression
1999
Prospects for Cardiovascular Research
2001 StandoutNobel
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
2002 StandoutNature
Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids.
1996
Ribozyme Targeting of Receptor for Advanced Glycation End Products in Mouse Mesangial Cells
1998
Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases
2000 Nature
Ranibizumab for Neovascular Age-Related Macular Degeneration
2006 Standout
The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
2008
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
2006 Standout
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
2001
Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats.
1996
Regulated portals of entry into the cell
2003 StandoutNature
Angiogenesis in cancer and other diseases
2000 StandoutNature
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
The effect of advanced glycation end-product formation upon cell-matrix interactions
1999
Characterization and Functional Analysis of the Promoter of RAGE, the Receptor for Advanced Glycation End Products
1997
Macrophage migration and gene expression in response to tumor hypoxia
2005
VEGF Gene Delivery to Muscle
1998
Age-dependent Defect in Vascular Endothelial Growth Factor Expression Is Associated with Reduced Hypoxia-inducible Factor 1 Activity
2000 StandoutNobel
Induction of synthesis and secretion of interleukin 1β in the human monocytic THP-1 cells by human serum albumins modified with methylglyoxal and advanced glycation endproducts
1996
Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.
1995
Lymphangiogenesis in development and human disease
2005 StandoutNature
Gene therapy for myocardial angiogenesis
1999
Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts
1998
Does Accumulation of Advanced Glycation End Products Contribute to the Aging Phenotype?
2010
Vascular permeability factor/vascular endothelial growth factor:A multifunctional angiogenic cytokine
1997
Vascular Endothelial Growth Factor: Molecular and Biological Aspects
1999
Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis
2000
The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis.
1996
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
1995
VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment
2004 Standout
Activation of the Receptor for Advanced Glycation End Products Triggers a p21 -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress
1997
Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis
1995
RAGE: A New Target for the Prevention and Treatment of the Vascular and Inflammatory Complications of Diabetes
2000
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
1996 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Vascular-specific growth factors and blood vessel formation
2000 StandoutNature
Caveolae: From Cell Biology to Animal Physiology
2002
Fibulin-5/DANCE is essential for elastogenesis in vivo
2002 StandoutNatureNobel
The role of vascular endothelial growth factor in pathological angiogenesis
1995
Alzheimer's Disease
2010 Standout
Inflammation in atherosclerosis
2002 StandoutNature
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes
2004
Blockade of Receptor for Advanced Glycation End-Products Restores Effective Wound Healing in Diabetic Mice
2001
Origin and physiological roles of inflammation
2008 StandoutNature
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells
1999
Sp1-binding Elements in the Promoter of RAGE Are Essential for Amphoterin-mediated Gene Expression in Cultured Neuroblastoma Cells
1998
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
1996 StandoutNature
Atherogenesis and Advanced Glycation: Promotion, Progression, and Preventiona
1997
Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1α
1998 StandoutNobel
Atherosclerosis
2000 StandoutNature
Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products.
1993
The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities
1996
Carbon Monoxide and Nitric Oxide Suppress the Hypoxic Induction of Vascular Endothelial Growth Factor Gene via the 5′ Enhancer
1998 StandoutNobel
Frailty in elderly people
2013 Standout
Angiogenesis as a therapeutic target
2005 StandoutNature
VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells
1999 Standout
Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-κB Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling Pathways
1999
Molecular mechanisms of ageing in connective tissues
2001
Novel Expression of Vascular Endothelial Growth Factor Receptor (VEGFR)-3 and VEGF-C on Corneal Dendritic Cells
2003
Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia
1999
RAGE Mediates a Novel Proinflammatory Axis
1999 Standout
Arterial Gene Transfer for Therapeutic Angiogenesis in Patients with Peripheral Artery Disease. St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Massachusetts
1996
Neutrophil Migration Mechanisms, with an Emphasis on the Pulmonary Vasculature
2000
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
1999 StandoutScience
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Molecular Mechanisms of Coronary Collateral Vessel Growth
1996
Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins.
1994
Advanced Glycation End Products
2006 Standout
Hypoxia-inducible factor 1α protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations
2000 StandoutNobel
Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins.
1996
Local Delivery of Vascular Endothelial Growth Factor Accelerates Reendothelialization and Attenuates Intimal Hyperplasia in Balloon-Injured Rat Carotid Artery
1995
Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins
1994
Glycation, Inflammation, and RAGE
2003
Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1
1996
The Biology of Vascular Endothelial Growth Factor
1997 Standout
Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.
1992
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
2005 Standout
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
1999 StandoutScience
Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE
2002
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
2014
Covalent dimerization of vascular permeability factor/vascular endothelial growth factor is essential for its biological activity. Evidence from Cys to Ser mutations
1994
Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats.
1997
Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues
2004
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
2001
Induction of Macrophage VEGF in Response to Oxidized LDL and VEGF Accumulation in Human Atherosclerotic Lesions
1998
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
1996 StandoutNobel
RAGE: therapeutic target and biomarker of the inflammatory response—the evidence mounts
2009
Activation of Receptor for Advanced Glycation End Products
1999
ADVANCED PROTEIN GLYCOSYLATION IN DIABETES AND AGING
1995
The endothelial cell binding site for advanced glycation end products consists of a complex: an integral membrane protein and a lactoferrin-like polypeptide
1994
CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis
2008
Fat Mobilization in Adipose Tissue Is Promoted by Adipose Triglyceride Lipase
2004 StandoutScience
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.
1994
Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products
2003
ZD4190: an orally active inhibitor of vascular endothelial growth factor signaling with broad-spectrum antitumor efficacy.
2000
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues.
1993
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
1996 StandoutNature
Advanced Glycation End Product (AGE)–Mediated Induction of Tissue Factor in Cultured Endothelial Cells Is Dependent on RAGE
1997
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells.
2000
Identification of Galectin-3 As a High-Affinity Binding Protein for Advanced Glycation End Products (AGE): A New Member of the AGE-Receptor Complex
1995
Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells
1997
RAGE Axis
2004
Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE
2001
Works of J Kao being referenced
Arachidonic Acid Influences Proinflammatory Gene Induction by Stabilizing the Inhibitor-κBα/Nuclear Factor-κB (NF-κB) Complex, thus Suppressing the Nuclear Translocation of NF-κB
1997
Ibuprofen: new explanation for an old phenomenon
1999
Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes
1993
Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes
1993
Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms.
1992
Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II.
1994
Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface.
1992